Previous studies have shown that the type 1 insulin-like growth factor receptor is over expressed in bladder cancer, and high doses of human insulin and insulin glargine can promote bladder cancer cell proliferation in vitro [22, 23]. This evidence concerns the gene INS and urinary bladder cancer.